Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05033028 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Smartphones for Opiate Addiction Recovery

Study acronym: SOAR
StatusRecruiting
PhasePhase 3
Started2021-11-01
View on ClinicalTrials.gov ↗

Amendment history

2026-06-22
Study Status v12
Completion pushed: 2027-05-31 → 2027-12-01
Primary completion date2027-05-31→2027-06-01
2026-02-24
Study Status v11
Primary completion date2026-05-31→2027-05-31
Completion date2026-05-31→2027-05-31
2025-04-09
Study Status, Contacts/Locations v10
Primary completion date2026-04-30→2026-05-31
Completion date2026-04-30→2026-05-31
Study sitescontacts updated at 1 of 2 sites
2025-03-04
Study Status, Study Design v9
Primary completion date2026-01-31→2026-04-30
Completion date2026-01-31→2026-04-30
Enrollment target510→225
2025-01-23
Study Status, Study Design v8
PhaseNot applicable→Phase 3
Show 7 earlier versions
2024-04-02
Study Status v7
Primary completion date2025-01-31→2026-01-31
Completion date2025-01-31→2026-01-31
2023-05-18
Study Status v6
Start date2021-12-31→2021-11-01
2023-05-03
Study Status v5
Re-verified, no change to tracked fields
2022-06-07
Study Status v4
Start date2021-11-01→2021-12-31
2022-06-06
Study Status v3
Primary completion date2025-01→2025-01-31
Completion date2025-01→2025-01-31
Start date2021-12-31→2021-11-01
2022-05-20
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2021-11→confirmed 2021-12-31
Study sitesdetails revised at 2 of 2 sites
2021-09-10
Study Status, Study Description, Outcome Measures v1
Secondary endpointsdetails revised at 1 of 1 entry
Study descriptionrevised
The primary goal in this mid-scale clinical trial is to test the hypothesis that clinicians who use the output of ourthe mobile system to adjust buprenorphine and methadone dosing [...]
2021-08-27
Original filing
Treatments for opioid addiction exist, but effectiveness is compromised when subjects use illicit opiates during treatment. Reuse rates during treatment can be high, and reducing illicit opiate use during treatment has thus recently become a major NIDA policy goal. The 5-minute battery indicates the numerical probability that a patient will reuse illicit opiates within the next 7-10 days.
Trial Details
NCT Number NCT05033028
Lead Sponsor NYU Langone Health
Conditions Opioid-use Disorder
Enrollment 225 participants
Start Date 2021-11-01
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-23